173 related articles for article (PubMed ID: 36254557)
1. Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis.
Zhang D; Wang J; Chen H; Yan S
Technol Cancer Res Treat; 2022; 21():15330338221131664. PubMed ID: 36254557
[No Abstract] [Full Text] [Related]
2. G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
Broselid S; Cheng B; Sjöström M; Lövgren K; Klug-De Santiago HL; Belting M; Jirström K; Malmström P; Olde B; Bendahl PO; Hartman L; Fernö M; Leeb-Lundberg LM
Clin Cancer Res; 2013 Apr; 19(7):1681-92. PubMed ID: 23554355
[TBL] [Abstract][Full Text] [Related]
3. Double-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data sets.
Yang F; Shao ZM
Onco Targets Ther; 2016; 9():6407-6415. PubMed ID: 27822058
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
5. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
6. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
7. HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
Tan RSYC; Ong WS; Lee KH; Lim AH; Park S; Park YH; Lin CH; Lu YS; Ono M; Ueno T; Naito Y; Onishi T; Lim GH; Tan SM; Lee HB; Ryu HS; Han W; Tan VKM; Wong FY; Im SA; Tan PH; Chan JY; Yap YS
BMC Med; 2022 Mar; 20(1):105. PubMed ID: 35296300
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.
Azim HA; Kroman N; Paesmans M; Gelber S; Rotmensz N; Ameye L; De Mattos-Arruda L; Pistilli B; Pinto A; Jensen MB; Cordoba O; de Azambuja E; Goldhirsch A; Piccart MJ; Peccatori FA
J Clin Oncol; 2013 Jan; 31(1):73-9. PubMed ID: 23169515
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic expression of G protein-coupled estrogen receptor 1 correlates with poor postoperative prognosis in non-small cell lung cancer.
Li ZH; Liu C; Liu QH; Wang J; Wang Y; Wang YF; Deng SJ; Li DB
J Thorac Dis; 2022 May; 14(5):1466-1477. PubMed ID: 35693608
[TBL] [Abstract][Full Text] [Related]
11. Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ Agonists.
Schmitz V; Bauerschmitz G; Gallwas J; Gründker C
Anticancer Res; 2022 Nov; 42(11):5187-5194. PubMed ID: 36288854
[TBL] [Abstract][Full Text] [Related]
12. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
13. Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells.
Loris J; Hanesch L; Bauerschmitz G; Gallwas J; Gründker C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762008
[TBL] [Abstract][Full Text] [Related]
14. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
Yan S; Jiao X; Li K; Li W; Zou H
Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
[TBL] [Abstract][Full Text] [Related]
15. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
[TBL] [Abstract][Full Text] [Related]
17. High tumor-infiltrating FoxP3
Qian F; Qingping Y; Linquan W; Xiaojin H; Rongshou W; Shanshan R; Wenjun L; Yong H; Enliang L
Eur J Surg Oncol; 2017 Jul; 43(7):1258-1264. PubMed ID: 28214052
[TBL] [Abstract][Full Text] [Related]
18. The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis.
Qu Q; Mao Y; Fei XC; Shen KW
PLoS One; 2013; 8(12):e82650. PubMed ID: 24324816
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.
Ibrahim EM; Al-Foheidi ME; Al-Mansour MM; Kazkaz GA
Breast Cancer Res Treat; 2014 Dec; 148(3):467-76. PubMed ID: 25361613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
